LG
LH icon

Laidlaw Group’s Labcorp LH Stock Holding History

Laidlaw Group’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-43,635
Closed -$3.42M – 89
2013
Q4 		$3.42M Buy
43,635
+76
+0.2% +$6.48K 1.83% 21
2013
Q3 		$3.71M Sell
43,559
-3,517
-7% -$296K 2.13% 15
2013
Q2 		$4.05M Buy
+47,076
New +$3.91M 2.28% 12

Other funds holding LH

DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
PIM
Perkins Investment Management Chicago, Illinois $8.09B AUM 25.47% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Laidlaw Group's LH Position: Q1 2014 in Review

Laidlaw Group sold out of Labcorp (LH) in Q1 2014, closing a stake of 43,635 shares — an estimated $3.42M sold.

Laidlaw Group first reported a position in LH in Q2 2013 and held it in 3 quarters. The position peaked at $4.05M in Q2 2013. 526 funds tracked by Wall St. Rank hold LH as of Q1 2014.

  • Laidlaw Group reported no remaining Labcorp position as of Q1 2014 after selling out during the quarter.
  • Laidlaw Group sold 43,635 Labcorp shares in Q1 2014, an estimated $3.42M.
  • Laidlaw Group first reported a position in Labcorp in Q2 2013 and held it in 3 quarters.
  • Laidlaw Group's Labcorp position peaked at $4.05M in Q2 2013.
  • 526 funds tracked by Wall St. Rank held Labcorp as of Q1 2014.

Based on Laidlaw Group's 13F filing for Q1 2014, filed 30 Apr 2014.